You just read:

VeroScience Continues Clinical Evaluation of Bromocriptine-QR (Cycloset) and Neurophysiological Investigations of Brain Dopamine Regulation of Metabolism with Eight Papers Presented at the 2015 American Diabetes Association Conference

News provided by

VeroScience, Inc.

Jun 06, 2015, 10:00 ET